mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.2 |